2012 Germany Hemostasis Diagnostics Market Outlook: Growth Opportunities and Strategies

Date: April 20, 2012
Pages: 406
Price:
US$ 5,400.00 US$ 4,590.00
License [?]:
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GE42D57FCACEN
Leaflet:

Download PDF Leaflet

2012 Germany Hemostasis Diagnostics Market Outlook: Growth Opportunities and Strategies
Report Highlights
  • Comprehensive 406-page analysis of the German hemostasis market, including:
  • Major issues pertaining to the German hemostasis laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Ten-year volume and sales forecasts for 40 hemostasis procedures performed in German hospitals, commercial laboratories, and physician offices, including typical hemostasis daily work loads.
  • Placement estimates for major automated and semi-automated systems.
  • Review of current instrumentation technologies, and a feature comparison of nearly 50 leading analyzers.
  • Ten-year reagent and instrument sales forecasts.
  • Sales and market shares of leading reagent and instrument suppliers.
  • Review of hemostasis technologies and their potential market applications.
  • Major opportunities for hemostasis instruments and consumables.
  • Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for instrument and reagent suppliers.
Contains 406 pages and 19 tables.
INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. MAJOR ROUTINE AND SPECIAL HEMOSTASIS TESTS


1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
  a. Introduction
  b. Factor II
  c. Factor V/Factor V Leiden
  d. Factor VII
  e. Factor VIII
  f. Factor IX
  g. Factor IXa
  h. Factor X (Stuart Factor)
  i. Factor Xa
  j. Factor XI
  k. Factor XII
  l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrand's Factor

B. INSTRUMENTATION REVIEW

Introduction
Benk Hemolab
Benk TRT Thrombotimer
Bio/Data MCA 310
Bio/Data MCA 210
Bio/Data PAP-4C D/4D/4C
Cardiovascular Diagnostics COAG
Diagnostica Stago STA Compact
Diagnostica Stago STA-R
Diagnostica Stago Star 4/8
Helena Laboratories Cascade 480
Helena Laboratories Cascade M
Helena Laboratories PACKS-4
Helena THOR
Instrumentation Laboratory ACL 100 and 1000 series
Instrumentation Laboratory ACL6000
Instrumentation Laboratory ACL7000
Instrumentation Laboratory ACL9000
Instrumentation Laboratory Electra 1000C
Instrumentation Laboratory Electra 1400C
Instrumentation Laboratory Electra 1600/C
Instrumentation Laboratory Electra 1800C
Instrumentation Laboratory Futura
ITC Hemochron 8000
Roche Diagnostics CoaguChek
Siemens BCS
Siemens BCT
Siemens BF II/Fibrintimer Series
Sysmex CA-50
Sysmex CA-500
Sysmex CA-1500
Sysmex CA-5000/CA-1000
Sysmex CA-6000
Sysmex CA-7000
Teco Coatron II/Jr./AccuStasis 5000
Trinity Biotech Amax CS190
Trinity Biotech Amax CS400
Trinity Biotech Coag-A-Mate Max
Trinity Biotech KC 40, 4A, 1A Series
Trinity Biotech MDA 180
Trinity Biotech Coag-A-Mate MTX
Trinity Biotech Coag-A-Mate RA4
Trinity Biotech Coag-A-Mate XC/Plus
Trinity Biotech Coag-A-Mate XM

C. MAJOR IN VITRO DIAGNOSTIC TECHNOLOGIES AND THEIR POTENTIAL APPLICATIONS

1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
  a. Applications
  b. Technological Principle
  c. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    EMIT
    Dot Immunobinding Assays
    Capillary Immunoassays
    Enzyme Amplification
    Electrochemical Immunoassay
  d. Fluorescent Immunoassays
    Fluorescence Polarization
    Time-Resolved Pulse Fluorescence
    Fluorescence Lifetime
  e. Latex Agglutination
  f. Immunoprecipitation
4. Microcomputers
5. Automation
6. Robotics
7. DNA Probes
  a. Overview
  b. Amplification Methods
    PCR
    Ligase Chain Reaction
    Branched DNA
    Q-Beta Replicase
    NASBA
    SDA
    3 SR
    HPA
    Two-Tiered System
    LAT
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors

D. WORLDWIDE MARKET OVERVIEW

1. Business Environment
2. Market Structure
3. Market Size and Growth
4. POC Testing Market

GERMANY

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES


A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types Of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
American Diagnostica
Avocet Medical
Axis-Shield
Beckman Coulter
Becton Dickinson
Bio/Data Corporation
Biosite
Chrono-Log
Corgenix Medical
Diagnostica Stago
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Nanogen
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
Trinity Biotech
ZyCare

LIST OF TABLES

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Worldwide, All Market Segments, Laboratories Performing Hemostasis Tests By Country, 2010
Worldwide, All Market Segments, Total Hemostasis Test Volume By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Reagent Market By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Instrument Market By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Diagnostics Market By Country, 2010-2020
Executive Summary Table: Germany, Total Hemostasis Diagnostics Market By Market Segment and Product Category, 2010-2020
Germany, Laboratories Performing Hemostasis Tests By Market Segment, 2010
Germany, Hospital Laboratories Performing Hemostasis Tests By Bed Size, 2010
Germany, Commercial/Private Laboratories Performing Hemostasis Tests By Annual Test Volume, 2010
Germany, Hospital Laboratories Average Daily Test Volume, 2010
Germany, Commercial/Private Laboratories Average Daily Test Volume, 2010
Germany, Physician Offices/Group Practice Average Daily Test Volume, 2010
Germany, Total Hemostasis Test Volume By Market Segment, 2010-2020
Germany, All Market Segments Hemostasis Test Volume, 2010-2020
Germany, Hospital Laboratories Hemostasis Test Volume, 2010-2020
Germany, Commercial/Private Laboratories Hemostasis Test Volume, 2010-2020
Germany, Physician Offices/Group Practices Hemostasis Test Volume, 2010-2020
Germany, Hemostasis Reagent Market By Market Segment, 2010-2020
Germany, Major Suppliers of Hemostasis Reagents, Estimated Sales and Market Shares, 2010
Germany, Hemostasis Instrument Market By Market Segment, 2010-2020
Germany, Major Suppliers of Hemostasis Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
Germany, Major Suppliers of Hemostasis Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
Germany, Major Suppliers of Hemostasis Analyzers, Estimated Instrument Sales and Market Shares, 2010
Germany, Total Hemostasis Diagnostics Market By Product Category, 2010-2020
Germany, Major Suppliers of Hemostasis Diagnostic Products, Estimated Sales and Market Shares, 2010
Skip to top


German Market for Vascular Access Devices 2008 US$ 4,495.00 Oct, 2008 · 73 pages
The 2012 German Infectious Disease Testing Market US$ 5,015.00 Mar, 2012 · 983 pages

Ask Your Question

2012 Germany Hemostasis Diagnostics Market Outlook: Growth Opportunities and Strategies
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: